Table 2. Preoperative medications (N=641)*.
| Medication¥† | Male |
Female |
P value§ | |||
|---|---|---|---|---|---|---|
| ≤65 years n [%] | >65 years n [%] | ≤65 years n [%] | >65 years n [%] | |||
| Overall | 265 [41] | 122 [19] | 158 [25] | 96 [15] | – | |
| Aspirin | 48 [18] | 25 [20] | 29 [18] | 14 [15] | 0.74 | |
| Lipid lowering agents | 67 [25] | 42 [34] | 20 [13] | 42 [44] | <0.0001 | |
| Anticoagulants | 4 [2] | 9 [7] | 1 [1] | 5 [5] | 0.0018 | |
| Antiplatelet agents | 7 [3] | 1 [1] | 3 [2] | 2 [2] | 0.79 | |
| β-Blockers | 53 [20] | 42 [34] | 52 [33] | 45 [47] | <0.0001 | |
| Calcium channel blockers | 22 [8] | 18 [15] | 15 [9] | 16 [17] | 0.066 | |
| Diuretics | 37 [14] | 24 [20] | 28 [18] | 21 [22] | 0.25 | |
| ACE inhibitors/ARBs | 86 [32] | 53 [43] | 47 [30] | 39 [41] | 0.051 | |
| Digitalis | 11 [4] | 13 [11] | 5 [3] | 16 [17] | <0.0001 | |
*, Robotic mitral valve repair procedure (RMVP) from May 2000 to April 2011; §, Fisher’s exact test across all columns; †, No patient received preoperative nitrates; ¥, Comparison group for binary variables was the absence of the characteristic. ACE, angiotensin converting enzyme; ARB, angiotensin receptor blocker.